Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-28

FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

The FDA approved a supplemental application for AMLODIPINE AND OLMESARTAN MEDOXOMIL from Micro Labs Limited, enabling its marketing as a fixed-dose combination …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE AND OLMESARTAN MEDOXIMIL (amlodipine and olmesartan medoxomil)

Snippet

SUPPL AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)